-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Amrize, Raises Price Target to $60

Benzinga·08/26/2025 15:06:06
Listen to the news
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $52 to $60.